A carregar...

CSF biomarkers for Alzheimer’s disease: Current utility and potential future use

Over the last 15 years, cerebrospinal fluid (CSF) biomarkers have been shown to be useful for both the diagnosis as well as the prognosis in Alzheimer’s disease. It has been shown the CSF levels of Aβ42 are a very good marker for the presence of amyloid deposition in the brain regardless of clinical...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Holtzman, David M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3233690/
https://ncbi.nlm.nih.gov/pubmed/22078172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neurobiolaging.2011.09.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!